Novo Owner Foundation Commits $62 Million to Quantum Chip Manufacturing in Copenhagen
The Novo Owner foundation, which controls Novo Nordisk, announced a $62 million investment to construct a quantum chip manufacturing plant in Copenhagen, marking a significant European entry into the emerging quantum technology sector.